HT29 is a highly malignant, adenocarcinoma-derived cell line with negligible levels of endogenous CaSR expression making these cells a good model to assess whether ectopic CaSR expression and function would restore their sensitivity to the anti-tumorigenic effects of Ca2 +. Here, CASR is linked to adenocarcinoma.